Sandro Vivona
Director, Discovery Biologics, Protein Sciences Merck & Co
Seminars
Thursday 5th February 2026
Integrating AI Models & Experimental Validation for De Novo Antibody & Biologic Design
11:30 am
- Moving beyond selection toward design-first approaches for novel antibodies and biologics
- Using AI-guided structural prediction to identify new binding sites and functional epitopes
- Designing antibodies with targeted MOAs: activation, switching, signalling
- Integrating AI models with experimental validation to accelerate biologic discovery pipelines
